vendredi 8 juillet 2011

Press review (July 9, 2011) – Revue de presse (9 juillet 2011)

Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
Better response, progression-free survival time seen with Tarceva in trial patients.
In U.S. News & World Report

Groundbreaking test may help personalize cancer treatment regimen
Cancer treatment in B.C. is about to get more personal — and more comfortable — after the announcement Monday of a groundbreaking medical project.
By Mike Raptis. In Vancouver Sun

Does Breast Augmentation Increase the Risk of Breast Cancer?
Many women wonder if there is a connection between breast augmentation and breast cancer; The FDA continues to support the use of breast implants, as extensive studies have proven their safety; The following is evidence of how closely the medical community reviews any possible connection between health issues and implants.
PR Newswire (press release)

Too many women get HPV tests: study
Doctors are testing women for human papillomavirus, or HPV -- some strains of which have been linked to cervical cancer -- more often than guidelines recommend, according to a new U.S. study.
By Elaine Lies. Reuters

Naked mole rat's genome 'blueprint' revealed
The industrious but unlovely naked mole rat is the latest creature to have its genome sequenced by scientists. The animals are also resistant to many diseases, particularly cancer. "I think that's the most interesting thing about them from a biomedical perspective," said Dr Magalhaes.
By Victoria Gill. BBC

Avastin Rejection Supported by Cancer Experts
Drug's value as metastatic breast cancer treatment still unclear, they say.
By Steven Reinberg. In U.S. News & World Report

Who should get a CT scan to screen for lung cancer?‎
Annual low-dose CT scans cut the death rate from lung cancer by 20 percent in heavy smokers and formerly heavy smokers.
By Jenifer GoodwinIn USA Today

Metabolic shift may offer early cancer clue
Cancer cells are well known for their altered metabolisms, which may help them generate the energy they need for rapid growth. Using an emerging imaging technology, researchers reporting in the July Cell Metabolism, a Cell Press publication, have discovered that those metabolic shifts actually develop even before detectable tumors form. By the same token, the studies in mice with liver cancer show that the altered tumor metabolism shifts back before established tumors shrink.
EurekAlert (press release)

The Cancer Genome Atlas completes detailed ovarian cancer analysis
As part of The Cancer Genome Atlas (TCGA ) project, UNC Lineberger researchers have contributed to the most comprehensive an integrated view of cancer genes for any cancer type produced to date.  The UNC team, which includes Charles Perou, PhD, professor of pathology and laboratory medicine and genetics, Neil Hayes, MD, associate professor of hematology/oncology, and Katie Hoadley, PhD, Research Associate, completed the microRNA and mRNA microarray analysis that contributed to the findings.
Media Newswire (press release)

La génétique des cancers du sein progresse
Il est connu depuis la dernière décennie que les mutations du gène BRCA2 ont pour conséquence d'augmenter le risque de cancer du sein. Les mutations sont héréditaires et l'augmentation de risque est transmissible de la mère à la fille. Des chercheurs du Centre de Recherche et d'Innovation en Biotechnologies de l'Université de Copenhague (BRIC) ont récemment révélé comment le gène BRCA2 fonctionnait. Ces connaissances seront utiles pour améliorer les traitements de cancer du sein.

Les Français sont de plus en plus nombreux à souffrir de maladies chroniques graves
A fin 2010, neuf millions de personnes souffraient d'une ou plusieurs maladies chroniques graves, telles que le diabète, le cancer ou la schizophrénie, rapporte Les Echos ce mercredi 29 juin, qui s'est procuré un rapport transmis aux administrateurs de l'assurance-maladie (CNAM). Depuis 2009, cette population s'est accrue de 3,9%.
Le Parisien

Aucun commentaire:

Enregistrer un commentaire